Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1991 1
1992 1
1993 7
1994 6
1995 3
1996 2
1997 3
1998 2
1999 4
2000 2
2001 4
2002 2
2003 2
2004 5
2005 4
2006 6
2007 6
2008 5
2009 8
2010 9
2011 9
2012 10
2013 12
2014 11
2015 12
2016 14
2017 8
2018 16
2019 11
2020 11
2021 14
2022 13
2023 10
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy.
Franken M, van der Wal E, Zheng D, den Hamer B, van der Vliet PJ, Lemmers RJLF, van den Heuvel A, Dorn AL, Duivenvoorden CGA, In't Groen SLM, Freund C, Eussen B, Tawil R, van Engelen BGM, Pijnappel PWWMP, van der Maarel SM, de Greef JC. Franken M, et al. Among authors: tawil r. Brain. 2024 Nov 18:awae379. doi: 10.1093/brain/awae379. Online ahead of print. Brain. 2024. PMID: 39556762
Andersen-Tawil syndrome.
Goslinga JA, PtáČek LJ, Tawil R, Fay A. Goslinga JA, et al. Among authors: tawil r. Handb Clin Neurol. 2024;203:59-67. doi: 10.1016/B978-0-323-90820-7.00001-X. Handb Clin Neurol. 2024. PMID: 39174254 Review.
AI driven analysis of MRI to measure health and disease progression in FSHD.
Riem L, DuCharme O, Cousins M, Feng X, Kenney A, Morris J, Tapscott SJ, Tawil R, Statland J, Shaw D, Wang L, Walker M, Lewis L, Jacobs MA, Leung DG, Friedman SD, Blemker SS. Riem L, et al. Among authors: tawil r. Sci Rep. 2024 Jul 5;14(1):15462. doi: 10.1038/s41598-024-65802-x. Sci Rep. 2024. PMID: 38965267 Free PMC article.
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Tawil R, Wagner KR, Hamel JI, Leung DG, Statland JM, Wang LH, Genge A, Sacconi S, Lochmüller H, Reyes-Leiva D, Diaz-Manera J, Alonso-Perez J, Muelas N, Vilchez JJ, Pestronk A, Gibson S, Goyal NA, Hayward LJ, Johnson N, LoRusso S, Freimer M, Shieh PB, Subramony SH, van Engelen B, Kools J, Leinhard OD, Widholm P, Morabito C, Moxham CM, Cadavid D, Mellion ML, Odueyungbo A, Tracewell WG, Accorsi A, Ronco L, Gould RJ, Shoskes J, Rojas LA, Jiang JG. Tawil R, et al. Lancet Neurol. 2024 May;23(5):477-486. doi: 10.1016/S1474-4422(24)00073-5. Lancet Neurol. 2024. PMID: 38631764 Clinical Trial.
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
Wong CJ, Friedman SD, Snider L, Bennett SR, Jones TI, Jones PL, Shaw DWW, Blemker SS, Riem L, DuCharme O, Lemmers RJFL, van der Maarel SM, Wang LH, Tawil R, Statland JM, Tapscott SJ. Wong CJ, et al. Among authors: tawil r. Hum Mol Genet. 2024 Apr 8;33(8):698-708. doi: 10.1093/hmg/ddae007. Hum Mol Genet. 2024. PMID: 38268317
222 results